Biological significance of the maximum standardized uptake values on positron emission tomography in non-small cell lung cancer

Journal of Surgical Oncology

Volumn 100, Issue 8, 2009, Pages 688-692

  Takenaka, Tomoyoshi ^a   Yano, Tokujiro ^a   Ito, Kensaku ^a   Morodomi, Yousuke ^a   Miura, Naoko ^a   Kawano, Daigo ^a   Shoji, Fumihiro ^a   Abe, Koichiro ^a   Honda, Hiroshi ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

FDG PET; Ki67; Non small cell lung cancer; VEGF

Indexed keywords

KI 67 ANTIGEN; VASCULOTROPIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE PERIOD; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 73449115676     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21386     Document Type: Article

References (27)

1. Vansteenkiste J, Fischer BM, Dooms C, et al.: Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: Systematic review. Lancet Oncol 2004;5:531-540.
2. Ung YC, Maziak DE, Vanderveen JA, et al.: 18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: A systematic review. J Natl Cancer Inst 2007;99: 1741-1743.
3. Bryant AS, Cerfolio RJ: The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules. Ann Thorac Surg 2006;82:1016-1020.
4. Som P, Atkins HL, Bandoypadhyay D, et al.: A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): Nontoxic tracer for rapid tumor detection. J Nucl Med 1980;21:670-675.
5. Woodard HQ, Bigler RE, Freed B: Expression of tissue isotope distribution. J Nucl Med 1975;16:958-959.
6. Nomori H, Watanabe K, Ohtsuka T, et al.: Fluorine 18-tagged fluorodeoxyglucose positron emission tomographic scanning to predict lymph node metastasis, invasiveness, or both, in clinical T1 N0 M0 lung adenocarcinoma. J Thorac Cardiovasc Surg 2004; 128:341-344.
7. Cerfolio RJ, Bryant AS, Ohja B, et al.: The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival. J Thorac Cardiovasc Surg 2005;130:151-159.
8. max) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): A systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. J Thorac Oncol 2008;3:6-12. Review.
9. Vesselle H, Freeman JD, Wiens L, et al.: Fluorodeoxyglucose uptake of primary non-small cell lung cancer at positron emission tomography: New contrary data on prognostic role. Clin Cancer Res 2007;13:3105-3106.
10. Vesselle H, Salskov A, Turcotte E, et al.: Relationship between non-small cell lung cancer FDG uptake at PET, tumor histology, and Ki-67 proliferation index. J Thorac Oncol 2008;3:971-978.
11. Plate KH, Breier G,Weich HA, et al.: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992;359:845-848.
12. Donnem T, Al-Saad S, Al-Shibli K, et al.: Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer. Clin Cancer Res 2007; 13:6649-6657.
13. Masuya D, Huang C, Liu D, et al.: The intratumoral expression of vascular endothelial growth factor and interleukin-8 associated with angiogenesis in nonsmall cell lung carcinoma patients. Cancer 2001;92:2628-2638.
14. Saad AG, Yeap BY, Thunnissen FB, et al.: Immunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinoma. Cancer 2008;113:2129-2138.
15. World Health Organization. Histological typing of lung and pleural tumors. 3rd edition. Geneva, Switzerland: Spriger-Verlag; 1999.
16. Mountain CF: Revisions in the international system for staging lung cancer. Chest 1997;111:1710-1717.
17. Sánchez-Mora N, Presmanes MC, Monroy V, et al.: Micropapillary lung adenocarcinoma: A distinctive histologic subtype with prognostic significance. Case series. Hum Pathol 2008;39: 324-330.
18. Paudyal B, Oriuchi N, Paudyal P, et al.: Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [18F]-2-fluro-2-deoxy-D-glucose positron emission tomography. Cancer Sci 2008;99:260-266.
19. de Geus-Oei LF, van Krieken JH, Aliredjo RP, et al.: Biological correlates of FDG uptake in non-small cell lung cancer. Lung Cancer 2007;55:79-87.
20. Tohma T, Okazumi S, Makino H, et al.: Relationship between glucose transporter, hexokinase and FDG-PET in esophageal cancer. Hepatogastroenterology 2005;52:486-490.
21. Higashi T, Saga T, Nakamoto Y, et al.: Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer. J Nucl Med 2002;43:173-180.
22. Imoto H, Osaki T, Taga S, et al.: Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma. J Thorac Cardiovasc Surg 1998;115:1007-1014.
23. Maeda K, Chung YS, Ogawa Y, et al.: Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 1996;77:858-863.
24. Inoue K, Ozeki Y, Suganuma T, et al.: Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumor progression. Cancer 1997;79:206-213.
25. Gasparini G, Toi M, Gion M, et al.: Prognostic significance of vascular endothelial growth factor protein in nodenegative breast carcinoma. J Natl Cancer Inst 1997;89:139-147.
26. Brown RS, Leung JY, Kison PV, et al.: Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer. J Nucl Med 1999;40:556-565.
27. Goel A, Mathupala SP, Pedersen PL: Glucose metabolism in cancer. Evidence that demethylation events play a role in activating type II hexokinase gene expression. J Biol Chem 2003;278:15333-15340.